WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORS →

DONATE →

CONTACT →

Latest News

Renée Maria Saliby: Kidney Cancer Research Champion

Renée Maria Saliby: Kidney Cancer Research Champion

Introducing Renée Maria Saliby, a dedicated young investigator in kidney cancer research! At just 27, Renée is blazing an inspring professional trail. Read on as she shares insights from her personal experiences and career pursuits, along with opportunities available for young researchers to...

SPRING ADVOCACY DAYS 2024 →

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DONATE NOW →

CONTACT →

Latest News

Empowering Young Voices: The Role of Youth in Kidney Cancer Advocacy

Empowering Young Voices: The Role of Youth in Kidney Cancer Advocacy

Scarlett Talcott, a vibrant 11-year-old from southern Montana, stands confidently in front of the Capitol Building during KidneyCAN's Advocacy Day. Living on a ranch with her parents, sister, and two brothers, Scarlett balances her love for the arts, crafting, and 4-H activities with a strong...

KCRS: KIDNEY CANCER RESEARCH SUMMIT →

RESEARCH OPPORTUNITIES →

NEWS →

Latest News

Renée Maria Saliby: Kidney Cancer Research Champion

Renée Maria Saliby: Kidney Cancer Research Champion

Introducing Renée Maria Saliby, a dedicated young investigator in kidney cancer research! At just 27, Renée is blazing an inspring professional trail. Read on as she shares insights from her personal experiences and career pursuits, along with opportunities available for young researchers to...

SUPPORT OUR WORK →

ROCK THE RUN 2023 →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

Join Our Community

Thanks to the hard work of advocates in the kidney cancer community, Congress has allocated $50 million in federal funding for research in 2023, bringing the six-year total to $235 million. Twice a year, KidneyCAN organizes calls and visits to congress to speak about the need for kidney cancer research.

We need your help to continue the progress in funding kidney cancer research!

FOR PATIENTS

Whether you are a patient, caregiver, family member or friend, there is no greater way to impact our lawmakers than to share how kidney cancer has impacted your life. The passion you have to pursue advanced treatments or cure will translate to action!  Patients and their families are at the heart of the grassroots army that has taken earmarked federal dollars for research from $0 to $50 million a year.

You and your loved ones can be a part of this army! There is strength and empowerment in “giving back.”

WHY ADVOCATE?

GET INVOLVED

SPEAK UP FOR FUNDING

KidneyCAN President Bryan Lewis and Dr. Andrew Smith of University of Alabama at Birmingham describe the importance of advocating for kidney cancer research funding and the impact it has on patient treatment.

SPEAK UP FOR FUNDING

KidneyCAN President Bryan Lewis and Dr. Andrew Smith of University of Alabama at Birmingham describe the importance of advocating for kidney cancer research funding and the impact it has on patient treatment.

The Need for Advocacy & Involvement

SPRING ADVOCACY DAYS 2023

RAISING AWARENESS

WAYS TO GIVE

From 2018-2023 we have had 980 advocates attend 1,316 congressional meetings.

Join us in helping to accelerate cures for kidney cancer. Your voice counts!

980
Advocates

1,316 congressional meetings

RESEARCH OPPORTUNITIES

KCRS INFO & PRESENTATIONS

FOR RESEARCHERS

You might be here on the KidneyCAN site learning more about the DoD CDMRP Kidney Cancer Research Awards.

Did you know you can impact the amount of research dollars ultimately allocated? Your firsthand account of the cost and value of cancer research provides a unique and needed perspective when we talk to congressional representatives.

Please take the opportunity and support these advocacy visits and be part of the powerful, united voice we need to make a difference! We need basic science and translational researchers to be part of this grassroots army.

 

For Patients

Advocacy

Research

Join Our Grassroots Army

We know that awareness of kidney cancer and its impact on many lives leads to a sense of urgency, a desire for solutions. Awareness leads to advocacy, and advocacy — joining to speak as one voice — leads to funding and research. That’s how we get to cures.

"On May 10, 2016, I was blindsided with a stage four #kidneycancer diagnosis. I thought I was going to die. The five-year survival rate that year for metastatic #RCC patients was 5%." -- Laura, on the other side of her participation in a clinical trial

-----------------------------

Join us for “Partners in Progress: Real Talk on Clinical Trials with Doctors and Patients,” a KidneyCAN Town Hall where exploration meets real-world experience.

👉Hear Directly from Experts: Renowned doctors Dr. Naomi Haas and Dr. Bradley McGregor will demystify the process and potential of clinical trials in kidney cancer care.
👉Gain Patient Perspectives: Patients will share their unfiltered experiences with clinical trials, offering insights that only someone who has walked this path can provide.
👉Ask Your Questions: This is your chance to get unvarnished information and advice straight from those deeply entrenched in the fight against kidney cancer.

Arm yourself with knowledge and join a community eager to support you at every step of your journey!

Register now and secure your spot: https://bit.ly/RealTalkTrials

"On May 10, 2016, I was blindsided with a stage four #kidneycancer diagnosis. I thought I was going to die. The five-year survival rate that year for metastatic #RCC patients was 5%." -- Laura, on the other side of her participation in a clinical trial

-----------------------------

Join us for “Partners in Progress: Real Talk on Clinical Trials with Doctors and Patients,” a KidneyCAN Town Hall where exploration meets real-world experience.

👉Hear Directly from Experts: Renowned doctors Dr. Naomi Haas and Dr. Bradley McGregor will demystify the process and potential of clinical trials in kidney cancer care.
👉Gain Patient Perspectives: Patients will share their unfiltered experiences with clinical trials, offering insights that only someone who has walked this path can provide.
👉Ask Your Questions: This is your chance to get unvarnished information and advice straight from those deeply entrenched in the fight against kidney cancer.

Arm yourself with knowledge and join a community eager to support you at every step of your journey!

Register now and secure your spot: https://bit.ly/RealTalkTrials
...

8 0
When Deb was diagnosed with stage IV kidney cancer six years ago, she thought she would miss out on a lot of life experiences. She turned to a clinical trial for hope.

Let's talk about the role of clinical trials in #kidneycancer treatment with those on the front lines. KidneyCAN's next Town Hall brings you insights from renowned doctors and experienced patients. 

🗓️ Wednesday, April 24th
⏰ 6 pm ET
💻 Free, Interactive Zoom Webinar
🥰 Community Social to follow

Register now to save your seat and ask your questions for the panel: https://bit.ly/RealTalkTrials

Let's navigate this path together!

When Deb was diagnosed with stage IV kidney cancer six years ago, she thought she would miss out on a lot of life experiences. She turned to a clinical trial for hope.

Let`s talk about the role of clinical trials in #kidneycancer treatment with those on the front lines. KidneyCAN`s next Town Hall brings you insights from renowned doctors and experienced patients.

🗓️ Wednesday, April 24th
⏰ 6 pm ET
💻 Free, Interactive Zoom Webinar
🥰 Community Social to follow

Register now to save your seat and ask your questions for the panel: https://bit.ly/RealTalkTrials

Let`s navigate this path together!
...

14 1
KidneyCAN is proud to partner with the American Association for Cancer Research to offer two $50,000 one-year grants for basic, translational, and/or clinical research projects. We want to stimulate creative approaches for treating #KidneyCancer. 

✅One page application!
⏰Apply by April 11! 

Learn more: https://bit.ly/AACR-KidneyCAN-Grant

Let's #AccelerateCures!

KidneyCAN is proud to partner with the American Association for Cancer Research to offer two $50,000 one-year grants for basic, translational, and/or clinical research projects. We want to stimulate creative approaches for treating #KidneyCancer.

✅One page application!
⏰Apply by April 11!

Learn more: https://bit.ly/AACR-KidneyCAN-Grant

Let`s #AccelerateCures!
...

11 0
Get the scoop on clinical trial participation from those who know! 

Plan to join KidneyCAN for our next Town Hall on April 24th: "Partners in Progress: Real Talk on Clinical Trials with Doctors and Patients." You'll learn everything you need to know as you weigh trial and treatment options for #KidneyCancer, from both doctor and patient panelists. 

Register now 👉 https://bit.ly/RealTalkTrials

Be sure to drop your questions in the comments here, as well as in the form when you register, so our team can ensure we answer as many as possible.

Get the scoop on clinical trial participation from those who know!

Plan to join KidneyCAN for our next Town Hall on April 24th: "Partners in Progress: Real Talk on Clinical Trials with Doctors and Patients." You`ll learn everything you need to know as you weigh trial and treatment options for #KidneyCancer, from both doctor and patient panelists.

Register now 👉 https://bit.ly/RealTalkTrials

Be sure to drop your questions in the comments here, as well as in the form when you register, so our team can ensure we answer as many as possible.
...

10 0
"I don't know what's gonna happen tomorrow or next year, but for right now, I've determined that I'm gonna live as much as I can, as well as I can."

Six years after his diagnosis of Stage IV kidney cancer, Dr. Adam Stern's story is a light of optimism in the face of adversity. His video update reminds us of the power of living fully each day.

As we mark the end of #KidneyCancerAwarenessMonth, we reflect on the journey of hope, resilience, and community we've shared. Indeed, we go forward together.

Stay connected with KidneyCAN on social media and explore our Patient Resource Center for valuable insights and guidance. Every day of the year, thank you for being part of our community to #AccelerateCures for #KidneyCancer.

🧡💚💪✨

"I don`t know what`s gonna happen tomorrow or next year, but for right now, I`ve determined that I`m gonna live as much as I can, as well as I can."

Six years after his diagnosis of Stage IV kidney cancer, Dr. Adam Stern`s story is a light of optimism in the face of adversity. His video update reminds us of the power of living fully each day.

As we mark the end of #KidneyCancerAwarenessMonth, we reflect on the journey of hope, resilience, and community we`ve shared. Indeed, we go forward together.

Stay connected with KidneyCAN on social media and explore our Patient Resource Center for valuable insights and guidance. Every day of the year, thank you for being part of our community to #AccelerateCures for #KidneyCancer.

🧡💚💪✨
...

12 2
This #KidneyCancerAwarenessMonth, remember that maintaining a healthy and active lifestyle during treatment is not just possible — it's empowering! 

Watch our Town Hall webinar to learn practical strategies for keeping your kidney function strong and your spirits high, directly from experts and fellow warriors on the same journey. 

Together, let's make health and activity our allies in the fight against #kidneycancer.

👉 Stay Active, Stay Informed: https://kidneycan.org/protecting-your-kidney-health/

This #KidneyCancerAwarenessMonth, remember that maintaining a healthy and active lifestyle during treatment is not just possible — it`s empowering!

Watch our Town Hall webinar to learn practical strategies for keeping your kidney function strong and your spirits high, directly from experts and fellow warriors on the same journey.

Together, let`s make health and activity our allies in the fight against #kidneycancer.

👉 Stay Active, Stay Informed: https://kidneycan.org/protecting-your-kidney-health/
...

12 0
Did you know? Fewer than 5% of cancer patients enroll in clinical trials, yet these trials are crucial for advancing treatment. This #KidneyCancerAwarenessMonth, let's change the narrative. 

Our KidneyCAN Patient Resource Center offers clear, accessible information on treatment options and clinical trials, helping you make informed decisions. 

👉 Access the Resources: https://bit.ly/KidneyCANPRCTrials

#KidneyCancerAwareness #ClinicalTrialParticipation #PatientEmpowerment #KidneyCAN

Did you know? Fewer than 5% of cancer patients enroll in clinical trials, yet these trials are crucial for advancing treatment. This #KidneyCancerAwarenessMonth, let`s change the narrative.

Our KidneyCAN Patient Resource Center offers clear, accessible information on treatment options and clinical trials, helping you make informed decisions.

👉 Access the Resources: https://bit.ly/KidneyCANPRCTrials

#KidneyCancerAwareness #ClinicalTrialParticipation #PatientEmpowerment #KidneyCAN
...

8 0
Exciting news from KidneyCAN! 🌟 

In partnership with AACR, we're directly funding two $50,000 research grants to advance kidney cancer treatments. It's a big leap toward new breakthroughs, and it's all thanks to the support of our incredible community. 

Together, we're #AcceleratingCures. 

https://bit.ly/AACR-KidneyCAN-Grant

Exciting news from KidneyCAN! 🌟

In partnership with AACR, we`re directly funding two $50,000 research grants to advance kidney cancer treatments. It`s a big leap toward new breakthroughs, and it`s all thanks to the support of our incredible community.

Together, we`re #AcceleratingCures.

https://bit.ly/AACR-KidneyCAN-Grant
...

8 0
Kidney cancer can occur in various forms, with the most common type being renal cell carcinoma (#RCC), which itself is categorized into several subtypes. The main subtypes of RCC include clear cell RCC, papillary RCC (which has two subtypes: type 1 and type 2), chromophobe RCC, and collecting duct RCC. There are also less common types of #KidneyCancer, such as medullary carcinoma, mucinous tubular and spindle cell carcinoma, and neuroblastoma-associated RCC.

Understanding  your specific diagnosis is key to building the right care team. Unfortunately, according to a survey conducted by the International Kidney Cancer Coalition (IKCC), many patients leave their first appointments without a clear understanding of their diagnosis. 

Our Patient Resource Center can help you make sense of the different types of kidney cancer and the specialists who will treat your condition. Check it out at www.kidneycan.org. 

#KidneyCancerAwarenessMonth

Kidney cancer can occur in various forms, with the most common type being renal cell carcinoma (#RCC), which itself is categorized into several subtypes. The main subtypes of RCC include clear cell RCC, papillary RCC (which has two subtypes: type 1 and type 2), chromophobe RCC, and collecting duct RCC. There are also less common types of #KidneyCancer, such as medullary carcinoma, mucinous tubular and spindle cell carcinoma, and neuroblastoma-associated RCC.

Understanding your specific diagnosis is key to building the right care team. Unfortunately, according to a survey conducted by the International Kidney Cancer Coalition (IKCC), many patients leave their first appointments without a clear understanding of their diagnosis.

Our Patient Resource Center can help you make sense of the different types of kidney cancer and the specialists who will treat your condition. Check it out at www.kidneycan.org.

#KidneyCancerAwarenessMonth
...

7 0